Director, Taussig Cancer Institute Phase I and Sarcoma Programs, Cleveland Clinic

Dale R. Shepard MD, PhD is the Director of the Taussig Phase I and Sarcoma programs at Cleveland Clinic.  In this role, Dr. Shepard oversees the early development of the new cancer therapies including the genomic-based treatments and immunotherapies that are revolutionizing the care of patients with cancer.  He sees nearly 200 sarcoma consults annually with patients from across the country including patients with desmoid tumors.  As a medical oncologist and clinical researcher, he has been the principal investigator for dozens of clinical trials and has been a recipient of a National Cancer Institute Cancer Clinical Investigator Team Leadership Award.  Dr. Shepard is a thought leader for management of sarcoma, gastrointestinal and genitourinary cancers and has been a consultant for many pharmaceutical companies.  Dr. Shepard earned a PhD in Pharmacology and his MD at The Ohio State University and completed a Clinical Pharmacology fellowship at the University of Chicago.